[Clinical experiences with the new bactericidal broad-band chemotherapeutic drug co-tetroxazine].
D000328:Adult; D000368:Aged; D000892:Anti-Infective Agents, Urinary / Q000627:therapeutic use; D004338:Drug Combinations / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011743:Pyrimidines / Q000627:therapeutic use*; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D013411:Sulfadiazine / Q000627:therapeutic use*; D014552:Urinary Tract Infections / Q000188:drug therapy*
D000892:Anti-Infective Agents, Urinary; D004338:Drug Combinations; D011743:Pyrimidines; D013411:Sulfadiazine; C026860:sulfadiazine, tetroxoprim drug combination
Klinische Erfahrungen mit dem neuen bakteriziden Breitband-Chemotherapeutikum Co-tetroxazin.